However, more recent evidence using ChIP-seq has shown that the BIM gene is associated with H3K27me3 in primary patient samples (Scott et al., 2016; Figure 1), suggesting that repression of BIM can be facilitated in multiple ways in CML. This evidence concerns the gene BCL2L11 and chronic myelogenous leukemia, BCR-ABL1 positive.